INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

Impact · against what's priced in

The news is neutral for BE as the current price has already absorbed the impact of the class action lawsuits and supply chain risks. For BEAM and TYRA, the initiation of securities fraud investigations following adverse clinical data introduces new legal and regulatory risks.

BE−0.05: Already priced in
The price assumes: immediate reality of the class action lawsuits regarding scandium sourcing

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

What matters in this story

ENDAVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endava plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DAVA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

What matters in this story

ENDAVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endava plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DAVA

How each ticker is affected

Track these names every morning.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

HIMS FINAL DEADLINE: ROSEN, A TRUSTED INVESTOR RIGHTS LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NVE Corporation Investors to Inquire About Securities Class Action Investigation - NVEC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

What matters in this story

Next reads from the same story arc

ENDAVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endava plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DAVA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

What matters in this story

Next reads from the same story arc

ENDAVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endava plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DAVA

How each ticker is affected

Track these names every morning.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

HIMS FINAL DEADLINE: ROSEN, A TRUSTED INVESTOR RIGHTS LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NVE Corporation Investors to Inquire About Securities Class Action Investigation - NVEC